缩写名/全名 |
BMC CANCER
BMC CANCER |
||||||||||||||||||||||||
ISSN号 | 1471-2407 | ||||||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||||||
影响因子 | 2015:3.265, 2016:3.288, 2017:3.288, 2018:2.933, 2019:3.15, | ||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||
出版周期 | Irregular | ||||||||||||||||||||||||
年文章数 | 1240 | ||||||||||||||||||||||||
出版年份 | 2001 | ||||||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||||||
审稿周期(仅供参考) | 平均6.8月 |
||||||||||||||||||||||||
录用比例 | 约38.12% | ||||||||||||||||||||||||
投稿链接 | https://www.editorialmanager.com/bcan/default.aspx | ||||||||||||||||||||||||
投稿官网 | http://bmccancer.biomedcentral.com/ | ||||||||||||||||||||||||
h-index | 111 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2407%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | A lung cancer patient with deep vein thrombosis:a case report and literature review Author: Yungu Chen, Yiu Sing Tsang, Xiaoxia Chou, Jiong Hu, Qing Xia Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5513-8 DOI |
2. | Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS Author: Yuanhang Zhu, Chenchen Ren, Li Yang, Xiaoan Zhang, Ling Liu, Zhaoxin Wang Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5492-9 DOI |
3. | Correction to: Axin gene methylation status correlates with radiosensitivity of lung cancer cells Author: Lian-He Yang, Yang Han, Guang Li, Hong-Tao Xu, Gui-Yang Jiang, Yuan Miao, Xiu-Peng Zhang, Huan-Yu Zhao, Zheng-Fan Xu, Maggie Stoecker, Endi Wang, Ke Xu, En-Hua Wang Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5491-x DOI |
4. | Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies Author: Liyun He, Huan Deng, Jun Lei, Fengming Yi, Jine Li, Xiu De Fan, Yiping Wei, Jianjun Xu, Wenxiong Zhang Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5487-6 DOI |
5. | First-line cetuximab versus bevacizumab for <Emphasis Type="Italic">RAS</Emphasis> and <Emphasis Type="Italic">BRAF</Emphasis> wild-type metastatic colorectal cancer: a systematic review and meta-analysis Author: Bobo Zheng, Xin Wang, Mingtian Wei, Quan Wang, Jiang Li, Liang Bi, Xiangbing Deng, Ziqiang Wang Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5481-z DOI |
6. | Correction to: The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer Author: Ping Zhao, Jun Wu, Feiteng Lu, Xuan Peng, Chenlin Liu, Nanjin Zhou, Muying Ying Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5478-7 DOI |
7. | First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers Author: Ying Fan, Shu Li, Xiaoyan Ding, Jian Yue, Jun Jiang, Hong Zhao, Rui Hao, Weiliang Qiu, Kezhen Liu, Ying Li, Shengdian Wang, Limin Zheng, Bin Ye, Kun Meng, Binghe Xu Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5471-1 DOI |
8. | The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis Author: Liping Qiu, Hanlu Zheng, Xiaoying Zhao Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5466-y DOI |
9. | Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report Author: Mengqi Jin, Yongxian Hu, Wenjun Wu, Yi Luo, Yamin Tan, Jian Yu, Aiyun Jin, Luxin Yang, He Huang, Guoqing Wei Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5464-0 DOI |
10. | Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial Author: Liang-Cheng Chen, Wen-Yen Chiou, Hon-Yi Lin, Moon-Sing Lee, Yuan-Chen Lo, Li-Wen Huang, Chun-Ming Chang, Tsung-Hsing Hung, Chih-Wen Lin, Kuo-Chih Tseng, Dai-Wei Liu, Feng-Chun Hsu, Shih-Kai Hung Journal: BMC CANCER, 2019, Vol.19, , DOI:10.1186/s12885-019-5461-3 DOI |
|
|